These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26047923)

  • 21. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
    Tapias V; Cannon JR; Greenamyre JT
    J Neurosci Res; 2010 Feb; 88(2):420-7. PubMed ID: 19681169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons.
    Aguirre P; Mena NP; Carrasco CM; Muñoz Y; Pérez-Henríquez P; Morales RA; Cassels BK; Méndez-Gálvez C; García-Beltrán O; González-Billault C; Núñez MT
    PLoS One; 2015; 10(12):e0144848. PubMed ID: 26658949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.
    Lin CH; Huang JY; Ching CH; Chuang JI
    J Pineal Res; 2008 Mar; 44(2):205-13. PubMed ID: 18289173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estradiol protects dopaminergic neurons in a MPP+Parkinson's disease model.
    Sawada H; Ibi M; Kihara T; Honda K; Nakamizo T; Kanki R; Nakanishi M; Sakka N; Akaike A; Shimohama S
    Neuropharmacology; 2002 Jun; 42(8):1056-64. PubMed ID: 12128007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymoquinone protects dopaminergic neurons against MPP+ and rotenone.
    Radad K; Moldzio R; Taha M; Rausch WD
    Phytother Res; 2009 May; 23(5):696-700. PubMed ID: 19089849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
    Mena MA; Casarejos MJ; García de Yébenes J
    J Neural Transm (Vienna); 1999; 106(11-12):1105-23. PubMed ID: 10651107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis.
    Klintworth H; Newhouse K; Li T; Choi WS; Faigle R; Xia Z
    Toxicol Sci; 2007 May; 97(1):149-62. PubMed ID: 17324951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP(+)-induced degeneration.
    Hartikka J; Staufenbiel M; Lübbert H
    J Neurosci Res; 1992 Jun; 32(2):190-201. PubMed ID: 1357186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system.
    Andres RH; Ducray AD; Pérez-Bouza A; Schlattner U; Huber AW; Krebs SH; Seiler RW; Wallimann T; Widmer HR
    Cell Transplant; 2005; 14(8):537-50. PubMed ID: 16355565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docosahexaenoic acid protection in a rotenone induced Parkinson's model: Prevention of tubulin and synaptophysin loss, but no association with mitochondrial function.
    Serrano-García N; Fernández-Valverde F; Luis-Garcia ER; Granados-Rojas L; Juárez-Zepeda TE; Orozco-Suárez SA; Pedraza-Chaverri J; Orozco-Ibarra M; Jiménez-Anguiano A
    Neurochem Int; 2018 Dec; 121():26-37. PubMed ID: 30342962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration.
    Radad K; Rausch WD; Gille G
    Neurochem Int; 2006 Sep; 49(4):379-86. PubMed ID: 16580092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ataxin-1 poly(Q)-induced proteotoxic stress and apoptosis are attenuated in neural cells by docosahexaenoic acid-derived neuroprotectin D1.
    Calandria JM; Mukherjee PK; de Rivero Vaccari JC; Zhu M; Petasis NA; Bazan NG
    J Biol Chem; 2012 Jul; 287(28):23726-39. PubMed ID: 22511762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures.
    Mercer LD; Kelly BL; Horne MK; Beart PM
    Biochem Pharmacol; 2005 Jan; 69(2):339-45. PubMed ID: 15627486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
    Tseng YT; Chang FR; Lo YC
    Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice.
    Ren Z; Yang N; Ji C; Zheng J; Wang T; Liu Y; Zuo P
    Neuropharmacology; 2015 Jun; 93():209-18. PubMed ID: 25680233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson's disease.
    Kim HG; Park G; Piao Y; Kang MS; Pak YK; Hong SP; Oh MS
    Food Chem Toxicol; 2014 Mar; 65():293-300. PubMed ID: 24389454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of toxicity in rotenone models of Parkinson's disease.
    Sherer TB; Betarbet R; Testa CM; Seo BB; Richardson JR; Kim JH; Miller GW; Yagi T; Matsuno-Yagi A; Greenamyre JT
    J Neurosci; 2003 Nov; 23(34):10756-64. PubMed ID: 14645467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N; Ferger B
    Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Puerarin protects dopaminergic neurons in Parkinson's disease models.
    Zhang X; Xiong J; Liu S; Wang L; Huang J; Liu L; Yang J; Zhang G; Guo K; Zhang Z; Wu P; Wang D; Lin Z; Xiong N; Wang T
    Neuroscience; 2014 Nov; 280():88-98. PubMed ID: 25218963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.